S'abonner

Orf-induced immunobullous disease: A distinct autoimmune blistering disorder - 24/04/13

Doi : 10.1016/j.jaad.2007.08.029 
Kevin P. White, MD a, Daniel C. Zedek, MD b, Wain L. White, MD c, d, e, Eric L. Simpson, MD a, Eric Hester, MD a, Lynne Morrison, MD a, Zelmira Lazarova, MD f, Debra Liu, MD g, Alessandra Scagliarini, DVM, PhD h, Stephen E. Kurtz, PhD i, Clifton R. White, MD a, Kim B. Yancey, MD f, Andrew Blauvelt, MD a, i, j,
a Department of Dermatology and Dermatopathology, Oregon Health and Science University, Portland, Oregon 
j Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, Oregon 
b Department of Pathology, University of North Carolina, Chapel Hill, North Carolina 
c Department of Dermatology, University of North Carolina, Chapel Hill, North Carolina 
d Department of Pathology, Wake Forest University, Winston-Salem, North Carolina 
e Greensboro Pathology Associates PA, Greensboro, North Carolina 
f Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin 
g Triad Dermatology PA, Winston-Salem, North Carolina 
h Dipartimento di Sanita Pubblica Veterinaria e Patologia Animale, Alma Mater Studiorum, Universita di Bologna, Bologna, Italy 
i Dermatology Service, Veterans Affairs, Portland, Oregon 

Reprint requests: Andrew Blauvelt, MD, Department of Dermatology, Oregon Health and Science University, 3710 SW US Veterans Hospital Rd, Mail Code R&D 55, Portland, OR 97239.

Abstract

Background

Many complications have been reported after orf infection, including lymphadenopathy, secondary bacterial infection, and erythema multiforme. Rare associations with papulovesicular eruptions, including a bullous pemphigoid-like eruption, have also been described.

Objectives

Our purpose was to clinically, histologically, and immunologically characterize two cases of orf-induced blistering disease, and to determine whether this condition represented a novel disease entity distinct from known immunobullous diseases.

Methods

Two patients were clinically described and skin biopsy specimens were collected for routine histology, direct immunofluorescence studies, and polymerase chain reaction analysis to detect orf viral DNA. Patients’ sera were assessed for autoantibodies by indirect immunofluorescence studies using normal-appearing human salt-split skin, by Western blot analysis using keratinocyte extracts, dermal extracts, and recombinant type VII collagen, and immunoprecipitation studies of extracts from biosynthetically radiolabeled human keratinocytes.

Results

Two distinctive cases of severe, diffuse blistering eruptions after orf infection are described. In one patient, orf virus DNA was detected in the inciting orf lesion, but not in blistered skin, ruling out disseminated orf infection as a cause of the blisters. In both cases, histology revealed subepidermal blisters with mixed inflammatory cell infiltrates containing neutrophils and eosinophils, direct immunofluorescence microscopy studies demonstrated IgG and C3 deposited at the dermoepidermal junctions of perilesional skin, and indirect immunofluorescence studies demonstrated circulating antibasement membrane IgG that bound the dermal side of salt-split skin. Extensive immunoblot and immunoprecipitation studies failed to reveal a consistent, identifiable autoantigen.

Limitations

We describe only two cases. The autoantigen recognized by circulating autoantibodies was not identified.

Conclusions

Orf-induced immunobullous disease is a unique disease entity that is clinically and immunologically distinct from bullous pemphigoid, epidermolysis bullosa acquisita, and other known immunobullous conditions.

Le texte complet de cet article est disponible en PDF.

Abbreviations used : BP, CP, EBA


Plan


 Supported in part by National Institutes of Health Grant RO1 AR048982 (Dr Yancey).
 Conflicts of interest: None declared.
 The first case was presented in part at the Society for Investigative Dermatology Annual Meeting in May 5, 2006 in Philadelphia, Pennsylvania, and the second case was presented in part at the American Society of Dermatopathology Annual Meeting on October 26, 2006, in Chicago, Illinois.


© 2008  American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 58 - N° 1

P. 49-55 - janvier 2008 Retour au numéro
Article précédent Article précédent
  • Bullous pemphigoid in infancy: Clinical and epidemiologic characteristics
  • Orith Waisbourd-Zinman, Dani Ben-Amitai, Arnon D. Cohen, Meora Feinmesser, Daniel Mimouni, Ayelet Adir-Shani, Marina Zlotkin, Alex Zvulunov
| Article suivant Article suivant
  • The prevalence of acne in adults 20 years and older
  • Christin N. Collier, Julie C. Harper, Wendy C. Cantrell, Wenquan Wang, K. Wade Foster, Boni E. Elewski

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.